UC San Diego Health First to Offer Novel Gene Therapy for Hemophilia B
January 10, 2025
January 10, 2025
LA JOLLA, California, Jan. 10 (TNSres) -- The University of California San Diego campus issued the following news:
* * *
Once considered a life-threatening diagnosis, new FDA-approved therapy provides patients long-term bleeding control with a single infusion
* * *
UC San Diego Health is one of a few health care systems on the West Coast to offer a new gene therapy for hemophilia B, a bleeding disorder that prevents blood from clotting properly . . .
* * *
Once considered a life-threatening diagnosis, new FDA-approved therapy provides patients long-term bleeding control with a single infusion
* * *
UC San Diego Health is one of a few health care systems on the West Coast to offer a new gene therapy for hemophilia B, a bleeding disorder that prevents blood from clotting properly . . .